COS-7 ceils transfected with parvovirus B19-simian virus 40 (SV40) hybrid vectors have previously been shown to express B19 structural proteins. In this study the morphology and antigenicity of B19 proteins expressed in these cells were investigated. At 84 h after transfection, approximately 10% of the COS-7 cells expressed B19 antigen, and the yield was equivalent to 2 x 103 to 2 x l0 s B19 particles/transfected cell. The B19 proteins self-assembled into capsids that were morphologically and antigenically similar to native B 19 virions, and could substitute for native antigen in a B19 IgM assay. Recombinant capsids lacking the recently described 11 kDa protein also resembled native virions.
Infection with parvovirus B19 is common, has a worldwide distribution and causes a spectrum of disease in humans (Anderson, 1987) . The virus does not, however, grow readily in cell culture and this has been a limiting factor in the preparation of antigen for diagnostic serology and studies of events in cellular infection. Until recently, the only source of antigen was serum-derived virus obtained, often at high titre, directly from infected humans by screening blood donors (Cohen et al., 1990) or patients with transient aplastic crisis (Koch & Adler, 1989) . However, B19-positive blood donations are rare, and large volumes of blood cannot be collected from aplastic patients. A further disadvantage of these materials is that their use poses an infection risk to laboratory workers (Cohen et al., 1988) .
Recent studies have therefore focused on producing a safe and renewable supply of BI9 antigen that mimics native proteins. Synthetic B19 peptides and fusion proteins from transformed Escherichia coli cultures have been evaluated as candidate antigens for diagnostic assays (Fridell et al., 1991 ; Rayment et al., 1990; Sisk & Berman, 1987) capsids. Recombinant B t 9 particles expressed in eukaryotic cells appear to be more promising for this purpose. Cells which have been used include a Chinese hamster ovary (CHO) cell line permanently transfected with a recombinant plasmid that expresses B19 structural proteins (Kajigaya et al., 1989) , Spodoptera frugiperda cells infected with BI9 recombinant baculoviruses Salimans et al., 1992; Rosenfeld et al., 1994; Kajigaya et al., 1991) and COS-7 cells transfected with B19-simian virus 40 (SV40) hybrid vectors (Beard et al., 1989) . In addition to the viral structural proteins, VP1 and VP2, and non-structural proteins, NS1 and NS2, these B19-SV40 vectors also express two classes of small proteins, the 11 kDa and 7"5 kDa proteins (St Amand & Astell, 1993; Luo & Astell, 1993) . The properties of recombinant B19 antigen from CHO cells and the baculovirus system have been documented. We now report a study of B19 capsids expressed in transfected COS-7 cells. Capsids from transfected cells expressing or not expressing the recently described 11 kDa protein were examined. In addition to their morphological and antigenic properties, their use in an assay for detecting B 19-specific IgM was investigated.
The plasmids used for transfections were: pSVOd/B19A170(A~), containing the B19 NS1, VP1 and VP2 genes; pSVOd, the origin vector without BI9 sequences; and pSVOd/B19A170(A~) l lkDa-, which contains a stop codon mutation in the small right-hand open reading frame to the B19 genome (Beard et aL, 1989; St Amand & Astell, 1993; Luo & Astell, 1993) . Transfections were performed with 0.2 to 10 lag quantities 0001-2936 © 1995 SGM of plasmid DNA per 60 mm dish seeded with 106 COS-7 cells grown overnight in Dulbecco's minimal essential medium until 80 % confluent. Production of B19 antigen by COS-7 cells transfected with pSVOd/B19A170(A4) (Beard et al., 1989) was detected by indirect immunofluorescence using human serum containing anti-B19 and anti-human FITC, by radioimmunoassay (RIA) (Cohen et al., 1983) and by immune electron microscopy (Mori et al., 1989) . By immunofluorescence, up to 10 % of the transfected COS-7 cells were positive for B19 antigen 48 h after transfection. There was a striking punctate pattern of staining with a cytoplasmic location. By RIA, production of B19 antigen was first detected 36 h after transfection and peaked at 84 h (Fig. 1) . The antigen was strongly cell-associated and the yield from one 60 mm dish seeded with l0 s cells approached that detected in the viraemic human serum, "Wi' (containing approximately 2 x 1011 B19 particles/ml), diluted 1 : 10 ( Fig. 1) . Generally, transfections yielded quantities of B19 antigen equivalent to the 'Wi' serum diluted 1 : 100 to 1:1000. As 10% of the COS-7 cells expressed B19 antigen the quantity of B19 antigen produced was estimated to be 2 x 1 0 ~ to 2 x 1 0 ~ B19 particles/ transfected COS-7 cell. The highest yield of B19 antigen was obtained when 1 gg quantities of plasmid DNA were used for the transfections (results not shown).
Immune electron microscopy of negatively stained extracts of pSVOd/B19A170(A~) transfected cells showed parvovirus capsids morphologically identical to native B19 particles ( Fig. 2a ). Capsids with a similar appearance were also present in cultures transfected with the plasmid pSVOd/B19A170(A4) 1 lkDa (Fig. 2b) .
B19 antigen produced by pSVOd/B19A170(A4) transfected COS-7 cells reacted by RIA with five of 27 MAbs available for testing (Table 1) , including VRL/B19/7. B19 antigen produced by pSVOd/B19A170(A~) 1 lkDa transfected COS-7 cells reacted by RIA with three of seven MAbs tested (Table 1) but failed to react with VRL/B19/7. Antibody capture RIA with B19 antigen produced by pSVOd/B19A170(A~) transfected COS-7 cells and MAb VRL/B19/7 was used to detect B19 IgM in a panel of 43 sera. The results with the recombinant antigen were compared with those of RIA for B19 IgM using native B19 antigen and MAb VRL/B19/11. Ten samples were B 19 IgM-negative (< 1 RIA unit) and nine were strongly positive (> 100 RIA units) with both the recombinant (Cohen et al., 1983) : O, LCDC, Ottowa, Canada (Yoshimoto et al., 1991) ; C, CDC Atlanta, USA (Anderson et al., 1986) ; B, Regional Virus Laboratory, Belfast, UK (O'Neill et al., 1992) ; F, Kyushu University, Fukuoka, Japan (Sato et al., 1991) . counts with cells transfected with pSVOd/B19A170(A4) P/N = counts with COS-7 cells transfected with pSVOd counts with cells transfected with pSVOd/B19A170(A4) 11 kDa- § P/N = counts with COS-7 cells transfected with pSVOd NT, Not tested.
DNA-and serum-derived antigens. There was a close correlation of B19 IgM levels determined by the two antigens in the remaining 24 positive sera (Fig. 3) .
The B19-SV40 hybrid vectors used in this study were previously shown to express B19 structural proteins in COS-7 cells (Beard et al., 1989) . We have now shown that the expressed structural proteins assemble into particles which are morphologically and antigenically similar to native B19 parvovirus.
We found that B19 particles from transfected COS-7 cells could substitute for native B19 antigen in antibody capture RIA for specific IgM although not all MAbs prepared with native B19 antigen were suitable for this assay. There was no loss of sensitivity in the B19 IgM RIA with COS-7 cell-derived B19 particles which, like material from transfected CHO cells (Kajigaya et al., 1989) or the baculovirus system (Brown et al., 1990; Kajigaya et al., 1991) , represent a safe (non-infectious) and renewable source of antigen for B19 serology. Moreover, in preliminary studies, the specificity of B19 IgM assays with antigens produced in eukaryotic cells has been good (Brown et al., 1990; Kajigaya et al., 1991) , in contrast to that with B19 antigens derived from prokaryotic systems (Rayment et al., 1990) or with synthetic peptides (Fridell et al., 1991) .
The yield of B 19 particles from COS-7 cells (approximately 2 x 10 a to 2 x 105 particles/cell) was similar to that reported for the transfected CHO cell line (3-11-5) (Kajigaya et al., 1989) . However, since the CHO line is permanently transformed it may prove more useful for antigen production than the transient expression of B19 in COS-7 cells described in this report. The baculovirus system appears to have even greater potential because the amount of antigen produced is equivalent to 2 x 106 B19 particles per insect cell (Brown et al., 1991) . Although the yield of antigen is greater in insect cells, the COS-7 cells described here provide an alternative for diagnosis which may be advantageous because they are mammalian in origin. Moreover, COS-7 cells transfected with pSVOd/B19A170(A4) are useful for identification of viral structural and non-structural proteins (Beard et al., 1989) and the 11 kDa and 7.5kDa proteins (St Amand & Astell, 1993; Luo & Astell, 1993) . This system is also more readily manipulated to express a subset of proteins or mutant proteins [e.g. the pSVOd/B19A170(A4) llkDa mutant].
Cells transfected with the pSVOd/B19A170(A4) 1 lkDa-mutant do not express the 11 kDa proteins but do produce empty capsids (Fig. 2 b) . However, although not essential for capsid formation, the 11 kDa proteins may affect capsid antigenicity since 11 kDa deficient capsids had an altered pattern of reactivity with the anti-B19 MAb VRL/B19/7 compared to capsids derived from the pSVOd/B19A170(A4) plasmid (Table 1) . Recombinant capsids containing VP2 alone can agglutinate human red cells (Brown & Cohen, 1992) , by binding to the B19 cellular receptor, blood group P antigen or globoside (Brown et al., 1993) . Therefore, the 11 kDa proteins are unlikely to have a role in virus-receptor binding. However, they may be involved in the later stages of viral entry-viral endocytosis, uncoating, or transportation to the nucleus. The recombinant capsids, with and without the 11 kDa protein, should be valuable in studying these events. In addition, the transfected COS-7 cells are currently being used in experiments to determine the functional role of the small B19 RNAs and both the 7"5 kDa and 11 kDa proteins.
